Laser atherectomy for treatment of femoropopliteal in-stent restenosis

Journal of Endovascular Therapy

Volumn 22, Issue 4, 2015, Pages 506-513

  Armstrong, Ehrin J ^a   Thiruvoipati, Thejasvi ^a   Tanganyika, Kundai ^a   Singh, Gagan D ^b   Laird, John R ^b  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Balloon angioplasty; In stent restenosis; Laser atherectomy; Patency; Peripheral artery disease; Reocclusion; Stent; Superficial femoral artery; Target lesion revascularization

Indexed keywords

AGED; ANGIOGRAPHY; ANKLE BRACHIAL INDEX; ARTICLE; ATHERECTOMY; CATHETER; CONTROLLED STUDY; ECHOGRAPHY; FEMALE; FEMOROPOPLITEAL IN-STENT RESTENOSIS; HUMAN; IN-STENT RESTENOSIS; LASER ATHERECTOMY; MAJOR CLINICAL STUDY; MALE; PEAK SYSTOLIC VELOCITY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; REVASCULARIZATION; TREATMENT OUTCOME; BLOOD FLOW VELOCITY; CLINICAL TRIAL; DUPLEX DOPPLER ULTRASONOGRAPHY; FEMORAL ARTERY; GRAFT OCCLUSION, VASCULAR; LOW LEVEL LASER THERAPY; MULTICENTER STUDY; POPLITEAL ARTERY; PROCEDURES; RETROSPECTIVE STUDY; STENT;

AGED; ANGIOGRAPHY; ANGIOPLASTY, BALLOON; ANKLE BRACHIAL INDEX; ATHERECTOMY; BLOOD FLOW VELOCITY; FEMALE; FEMORAL ARTERY; GRAFT OCCLUSION, VASCULAR; HUMANS; LASER THERAPY; MALE; POPLITEAL ARTERY; RETROSPECTIVE STUDIES; STENTS; TREATMENT OUTCOME; ULTRASONOGRAPHY, DOPPLER, DUPLEX;

EID: 84940181003     PISSN: 15266028     EISSN: 15451550     Source Type: Journal    
DOI: 10.1177/1526602815592133     Document Type: Article

References (37)

1. Dippel EJ, Makam P, Kovach R, et al; for the EXCITE ISR Investigators. Randomized controlled study of excimer laser atherectomy for treatment of femoropopliteal in-stent restenosis: initial results from the EXCITE ISR (EXCImer Laser Randomized Controlled Study for Treatment of FemoropopliTEal In-Stent Restenosis) Trial. JACC Cardiovasc Interv. 2015;8(1 pt A):92-101.
2. Singh GD, Armstrong EJ, Laird JR. Femoropopliteal in-stent restenosis: current treatment strategies. J Cardiovasc Surg. 2014;55:325-333.
3. Yeo KK, Malik U, Laird JR. Outcomes following treatment of femoropopliteal in-stent restenosis: a single center experience. Catheter Cardiovasc Interv. 2011;78:604-608.
4. Tosaka A, Soga Y, Iida O, et al. Classification and clinical impact of restenosis after femoropopliteal stenting. J Am Coll Cardiol. 2012;59:16-23.
5. Stabile E, Virga V, Salemme L, et al. Drug-eluting balloon for treatment of superficial femoral artery in-stent restenosis. J Am Coll Cardiol. 2012;60:1739-1742.
6. PATENT trial. Spectranetics' PATENT results support laser atherectomy to treat peripheral in-stent restenosis. Endovascular Today. http://evtoday.com/2013/01/spectraneticspatent-results-support-laser-atherectomy-to-treat-peripheral-instent-restenosis. Accessed May 15, 2015.
7. Dick P, Sabeti S, Mlekusch W, et al. Conventional balloon angioplasty versus peripheral cutting balloon angioplasty for treatment of femoropopliteal artery in-stent restenosis: initial experience. Radiology. 2008;248:297-302.
8. Schlager O, Dick P, Sabeti S, et al. Stenting of the superficial femoral artery endoluminal bypass in long de novo lesions and in-stent restenosis. J Endovasc Ther. 2006;13:701-710.
9. Liistro F, Angioli P, Porto I, et al. Paclitaxel-eluting balloon vs. standard angioplasty to reduce recurrent restenosis in diabetic patients with in-stent restenosis of the superficial femoral and proximal popliteal arteries: the DEBATE-ISR Study. J Endovasc Ther. 2014;21:1-8.
10. FAIR Trial compares DEB versus PTA for treating SFA in-stent restenosis. Endovascular Today. http://evtoday.com/2014/01/30/fair-trial-compares-deb-versus-pta-for-treating-sfa-in-stent-restenosis. Accessed May 15, 2015.
11. Laird JR, Yeo KK, Rocha-Singh K et al. Excimer laser with adjunctive balloon angioplasty and heparin-coated self-expanding stent grafts for the treatment of femoropopliteal artery instent restenosis: twelve-month results from SALVAGE study. Catheter Cardiovasc Interv. 2012;80:852-859.
12. Zeller T, Dake M, Tepe G, et al. Treatment of femoropopliteal in-stent restenosis with paclitaxel-eluting stents. JACC Cardiovasc Interv. 2013;6:274-281.
13. Trentmann J, Charalambous N, Djawanscer M, et al. Safety and efficacy of directional atherectomy for the treatment of in-stent restenosis of the femoropopliteal artery. J Cardiovasc Surg (Torino). 2010;51:551-560.
14. Sixt S, Cancino O, Treszl A, et al. Drug-coated balloon angioplasty after directional atherectomy improves outcomes in restenotic femoropopliteal arteries. J Vasc Surg. 2013;58:682-686.
15. Gandini R, Del Guidice C, Merolla S, et al. Treatment of chronic SFA in-stent occlusion with combined laser atherectomy and drug-eluting balloon angioplasty in patients with critical limb ischemia: a single-center, prospective, randomized study. J Endovasc Ther. 2013;20:805-814.
16. Armstrong EJ. Strategies for femoropopliteal in-stent restenosis. Endovascular Today. 2014;October:84-87.
17. Gorgani F, Telis A, Narakathu N, et al. Long-term outcomes of the Viabahn stent in the treatment of in-stent restenosis in the superficial femoral artery. J Invasive Cardiol. 2013;25:670-674
18. Virga V, Stabile E, Biamino G, et al. Drug-eluting balloon for the treatment of superficial femoral artery in-stent restenosis: 2-year follow-up. JACC Cardiovasc Interv. 2014;7:411-415.
19. Deloose K. RELINE: a randomized trial of Viabahn covered stents vs PTA. Presented at: The Leipzig Interventional Course; January 28-31, 2014; Leipzig, Germany.
20. Dake MD, Ansel GM, Jaff MR, et al. Paclitaxel eluting stents show superiority to balloon angioplasty and bare metal stents in femoropopliteal disease: twelve-month Zilver PTX randomized study results. Circ Cardiovasc Interv. 2011;4: 495-504.
21. Laird JR, Katzen BT, Scheinert D, et al. Nitinol stent implantation vs. balloon angioplasty for lesions in the superficial femoral and proximal popliteal arteries of patients with claudication: three-year follow-up from the RESILIENT randomized trial. J Endovasc Ther. 2012;19:1-9.
22. Schillinger M, Sabeti S, Loewe C, et al. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med. 2006;354:1879-1888.
23. Dake MD, Scheinert D, Tepe G, et al. Nitinol stents with polymer-free paclitaxel coating for lesions in the superficial femoral and popliteal arteries above the knee: twelve-month safety and effectiveness results from the Zilver PTX singlearm clinical study. J Endovasc Ther. 2011;18:613-623.
24. Krankenberg H, Schluter M, Steinkamp HJ, et al. Nitinol stent implantation versus percutaneous transluminal angioplasty in superficial femoral artery lesions up to 10 cm in length: the Femoral Artery Stenting Trial (FAST). Circulation. 2007;116;285-292.
25. Bosiers M, Torsello G, Gissler HM, et al. Nitinol stent implantation in long superficial femoral artery lesions: 12 month results of the DURABILITY I study. J Endovasc Ther. 2009;16:261-269.
26. Tepe G, Zeller T, Albrecht T, et al. Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg. N Engl J Med. 2008;358:689-699.
27. Werk M, Langner S, Reinkensmeier B, et al. Inhibition of restenosis in femoropopliteal arteries: paclitaxel-coated versus uncoated balloon: femoral paclitaxel randomized pilot trial. Circulation. 2008;118:1358-1365.
28. Armstrong EJ, Singh S, Singh GD, et al. Angiographic characteristics of femoropopliteal in-stent restenosis: association with long-term outcomes after endovascular intervention. Catheter Cardiovasc Interv. 2013;82:1168-1174.
29. Shammas NW, Shammas GA, Hafez A, et al. Safety and oneyear revascularization outcome of excimer laser ablation therapy in treating in-stent restenosis of femoropopliteal arteries: a retrospective review from a single center. Cardiovasc Revasc Med. 2012;13:341-344.
30. Popma JJ, Tiroch K, Almonacid A, et al. A qualitative and quantitative angiographic analysis of stent fracture late following sirolimus-eluting stent implantation. Am J Cardiol. 2009;103:923-929.
31. Shammas NW. Addressing challenges in the treatment of infrainguinal arterial disease: an endovascular specialist's perspective. J Invasive Cardiol. 2013;25:3B-6B.
32. Topaz O, Minisi AJ, Bernardo NL et al. Alterations of platelet aggregation kinetics with ultraviolet laser emission: the "stunned platelet" phenomenon. Thromb Haemost. 2001;86:1087-1093.
33. Shammas NW, Coiner D, Shammas GA, et al. Distal embolic event protection using excimer laser ablation in peripheral vascular interventions: results of the DEEP EMBOLI registry. J Endovasc Ther. 2009;16:197-202.
34. Lam RC, Shah S, Faried PL, et al. Incidence and clinical significance of distal embolization during percutaneous interventions involving the superficial femoral artery. J Vasc Surg. 2007;46:1155-1159.
35. Shammas NW, Shammas GA, Jerin M. Differences in patient selection and outcomes between SilverHawk atherectomy and laser ablation in the treatment of femoropopliteal in-stent restenosis: a retrospective analysis from a single center. J Endovasc Ther. 2013;20:844-852.
36. Schmidt A, Zeller T, Sievert H, et al. Photoablation using the Turbo-Booster and excimer laser for in-stent restenosis treatment: twelve-month results from the PATENT trial. J Endovasc Ther. 2014;21:52-60.
37. Dave RM, Patlola R, Kollmeyer K, et al. Excimer laser recanalization of femoropopliteal lesions and 1-year patency: results of the CELLO registry. J Endovasc Ther. 2009;16:665-675.